Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
McKinsey
Daiichi Sankyo
Cerilliant
Deloitte
Fuji
Express Scripts
US Department of Justice

Generated: July 18, 2018

DrugPatentWatch Database Preview

Halothane - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for halothane and what is the scope of halothane freedom to operate?

Halothane
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst, BH, Halocarbon, and Hospira, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for halothane.
Summary for halothane
Medical Subject Heading (MeSH) Categories for halothane
Synonyms for halothane
(.+/-.))-Halothane
(+-)-2-Bromo-2-chloro-1,1,1-trifluoroethane
1-bromo-1-chloro-2,2,2-trifluorethane
1-Bromo-1-chloro-2,2,2-trifluoroethane
1-Bromo-1-chloro-2,2,2-trifluoroethane, 99%
1,1-Trifluoro-2-bromo-2-chloroethane
1,1-Trifluoro-2-chloro-2-bromoethane
1,1,1-Trifluoro-2-bromo-2-chloroethane
1,1,1-Trifluoro-2-chloro-2-bromoethane
151-67-7
2-Brom-2-chlor-1,1,1-trifluorethan
2-Bromo-2-chloro-1,1-trifluoroethane
2-bromo-2-chloro-1,1,1-trifluoro-ethane
2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE
2-Bromo-2-chloro-1,1,1-trifluoroethane, >=99.0% (GC)
2-Bromo-2-chloro-1,1,1-trifluoroethane, >=99%
2,2-Trifluoro-1-chloro-1-bromoethane
2,2,2-Trifluoro-1-chloro-1-bromoethane
2979-EP2269610A2
2979-EP2277848A1
2979-EP2280006A1
2979-EP2281813A1
2979-EP2284160A1
2979-EP2289510A1
2979-EP2292589A1
2979-EP2298735A1
2979-EP2298767A1
2979-EP2314587A1
2979-EP2316457A1
2979-EP2316458A1
2979-EP2316825A1
2979-EP2316826A1
2979-EP2316827A1
2979-EP2316828A1
74925-63-6
AB01563314_01
AC1L1G7T
ACMC-1BHQY
AK166916
AKOS006227959
Alotano
Alotano [DCIT]
AN-23326
Anestan
BCQZXOMGPXTTIC-UHFFFAOYSA-
BCQZXOMGPXTTIC-UHFFFAOYSA-N
BDBM50112212
BRN 1736947
Bromchlortrifluoraethanum
Bromochlorotrifluoroethane
C07515
C2HBrClF3
CAS-151-67-7
CCG-213438
CCRIS 6244
CF3CHClBr
Chalothane
CHEBI:5615
CHEMBL931
Chlorobromotrifluoroethane
CS-4523
CTK4C7172
D-HALOTHANE
D00542
D0D8VE
DB-043111
DB01159
DSSTox_CID_5371
DSSTox_GSID_25371
DSSTox_RID_77767
DTXSID4025371
EINECS 205-796-5
Epitope ID:150925
Ethane, 1-bromo-1-chloro-2,2,2-trifluoro-
Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-
Ethane, 2-bromo-2-chloro-1,1,1-trifluoro-, (+-)-
Ethane, bromochlorotrifluoro-
Ethane,1,1-trifluoro-
Ethane,2-bromo-2-chloro-1,1,1-trifluoro-
Fluktan
Fluorotane
Fluothane
Fluothane (TN)
Freon 123B1
FT-0626853
Ftorotan
Ftorotan [Russian]
Ftuorotan
GTPL2401
Halan
Halotan
Halotano
Halotano [INN-Spanish]
Halothan
Halothane (JP15/USP/INN)
Halothane (JP17/USP/INN)
Halothane [Anaesthetics, volatile]
Halothane [INN:BAN:JAN]
Halothane, United States Pharmacopeia (USP) Reference Standard
Halothanum
Halothanum [INN-Latin]
Halsan
HMS2094K17
HSDB 6753
HY-B1010
I14-44700
InChI=1/C2HBrClF3/c3-1(4)2(5,6)7/h1H
J-008834
KB-21112
LS-881
MFCD00009602
MolPort-001-772-004
Narcotan
Narcotane
Narcotann ne-spofa
Narcotann NE-spofa [Russian]
Narkotan
NCGC00090868-01
NCGC00090868-02
NCGC00090868-03
NCGC00090868-05
NCGC00258404-01
NSC 143490
NSC-143490
NSC-760138
NSC143490
NSC760138
OR011456
OR167293
OR275914
Pharmakon1600-01505434
Phthorothanum
Rhodialothan
s4570
SBI-0206928.P001
SCHEMBL25588
SR-05000001969
SR-05000001969-1
TC-170891
Tox21_111033
Tox21_111033_1
Tox21_200850
WLN: GYEXFFF

US Patents and Regulatory Information for halothane

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Halocarbon HALOTHANE halothane LIQUID;INHALATION 080810-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bh HALOTHANE halothane LIQUID;INHALATION 084977-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira HALOTHANE halothane LIQUID;INHALATION 083254-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst FLUOTHANE halothane LIQUID;INHALATION 011338-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
Express Scripts
Cantor Fitzgerald
Chubb
US Army
Chinese Patent Office
Fish and Richardson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.